Cleared Traditional

K022567 - SEQUOIA SIGNATURE II DIAGNOSTIC ULTRASO...

K022567 is the FDA 510(k) clearance for SEQUOIA SIGNATURE II DIAGNOSTIC ULTRASO... by Acuson Corp.. It is a Class 2 Radiology device (product code IYN) cleared through the Traditional 510(k) pathway after a 11-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2002
Decision
11d
Days
Class 2
Risk

K022567 is an FDA 510(k) clearance for the SEQUOIA SIGNATURE II DIAGNOSTIC ULTRASOUND SYSTEM. Classified as System, Imaging, Pulsed Doppler, Ultrasonic within the IYN classification (a category covering pulsed Doppler and ultrasound imaging systems), Class II - Special Controls.

Submitted by Acuson Corp. (Mountain View, US). The FDA issued a Cleared decision on August 13, 2002 after a review of 11 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1550 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Acuson Corp. devices

Submission Details

510(k) Number K022567 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 02, 2002
Decision Date August 13, 2002
Days to Decision 11 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 107d · This submission: 11d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code IYN System, Imaging, Pulsed Doppler, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Tuv America, Inc.
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - IYN System, Imaging, Pulsed Doppler, Ultrasonic

All 793
Devices cleared under the same product code (IYN) and FDA review panel - the closest regulatory comparables to K022567.
BORIS PLATFORM DIAGNOSTIC ULTRASOUND SYSTEM
K030455 · Philips Ultrasound, Inc. · Mar 2003
ALOKA SSD-3500 ULTRASOUND SYSTEM
K023996 · Aloka Co., Ltd. · Dec 2002
SONOLINE ANTARES ULTRASOUND SYSTEM
K023720 · Siemens Medical Solutions USA, Inc. · Nov 2002
SSA-700A, APLIO DIAGNOSTIC ULTRASOUND SYSTEM
K022400 · Toshiba America Medical Systems, In.C · Aug 2002
PHILIPS M2424 DIAGNOSTIC ULTRASOUND SYSTEM &PHILIPS 21315 DIAGNOSTIC ULTRASOUND TRANSDUCER
K022303 · Philips Ultrasound, Inc. · Jul 2002
CYPRESS ULTRASOUND SYSTEM
K021497 · Acuson Corp. · Jul 2002